SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-213650
Filing Date
2022-08-05
Accepted
2022-08-05 16:30:40
Documents
5
Period of Report
2022-09-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A d366960ddef14a.htm DEF 14A 424743
2 GRAPHIC g366960dsp2.jpg GRAPHIC 20889
3 GRAPHIC g366960dsp2a.jpg GRAPHIC 2685
4 GRAPHIC g366960dsp4.jpg GRAPHIC 24109
5 GRAPHIC g366960dsp43.jpg GRAPHIC 7697
  Complete submission text file 0001193125-22-213650.txt   502866
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33057 | Film No.: 221141273
SIC: 2834 Pharmaceutical Preparations